Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers
Researchers found that low-dose extended-release niacin improves lipid levels and glycemic control in patients with diabetes. The therapy also raises high-density lipoprotein (HDL) cholesterol, a healthier type of cholesterol.